Literature DB >> 22205821

Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II.

Fabrizia Minandri1, Silvia D'Arezzo, Luísa C S Antunes, Christine Pourcel, Luigi Principe, Nicola Petrosillo, Paolo Visca.   

Abstract

Carbapenem-resistant Acinetobacter baumannii strains belonging to international clonal lineage II (ICL-II) have become predominant in intensive care units (ICUs) throughout Italy. Between 2005 and 2009, the carbapenem-hydrolyzing class D β-lactamase (CHDL) bla(OXA-23) gene became more prevalent than bla(OXA-58) among epidemic ICL-II strains showing extensive genetic similarity. These findings posed the question of whether CHDL gene replacement occurred in the homogeneous ICL-II population or a new OXA-23 clone(s) emerged and spread in ICUs. In this study, the changes in the ICL-II A. baumannii population and CHDL gene carriage were investigated in 30 genetically related isolates collected during the bla(OXA-58)-to-bla(OXA-23) transition period. Pulsotyping, randomly amplified polymorphic DNA (RAPD) analysis, and multilocus sequence typing (MLST) results were combined with multilocus variable-number tandem-repeat (VNTR) analysis (MLVA-8), siderotyping, and plasmid profiling to improve genotype-based discrimination between isolates. Pulsotyping, RAPD analysis, and MLST clustered isolates into a single type. MLVA-8 identified 19 types that clustered into three complexes. All OXA-23-producing isolates formed a single complex, while OXA-58 producers were split into two complexes. Southern blot analysis of the physical localization and genetic context of the CHDL genes showed that bla(OXA-58) was invariably located on plasmids, while bla(OXA-23) was present within Tn2006 on the chromosome or both the chromosome and plasmids. These data indicate that the apparently homogeneous population of CHDL-producing ICL-II strains was composed of several independent strains and that, between 2005 and 2009, distinct OXA-23 producers displaced the preexisting OXA-58 producers. Thus, MLVA-8 appears to be a suitable tool not only for investigating A. baumannii population structure but also for high-resolution epidemiological typing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22205821      PMCID: PMC3295171          DOI: 10.1128/JCM.05555-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Improved multiple-locus variable-number tandem-repeat assay for Staphylococcus aureus genotyping, providing a highly informative technique together with strong phylogenetic value.

Authors:  Christine Pourcel; Katia Hormigos; Lucie Onteniente; Olga Sakwinska; Ruud H Deurenberg; Gilles Vergnaud
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 2.  Acinetobacter: an old friend, but a new enemy.

Authors:  K J Towner
Journal:  J Hosp Infect       Date:  2009-08-22       Impact factor: 3.926

3.  Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa.

Authors:  Josselin Bodilis; Bart Ghysels; Julie Osayande; Sandra Matthijs; Jean-Paul Pirnay; Sarah Denayer; Daniel De Vos; Pierre Cornelis
Journal:  Environ Microbiol       Date:  2009-04-21       Impact factor: 5.491

4.  Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe.

Authors:  K J Towner; K Levi; M Vlassiadi
Journal:  Clin Microbiol Infect       Date:  2007-12-18       Impact factor: 8.067

Review 5.  Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.

Authors:  Raffaele Zarrilli; Maria Giannouli; Federica Tomasone; Maria Triassi; Athanassios Tsakris
Journal:  J Infect Dev Ctries       Date:  2009-06-01       Impact factor: 0.968

6.  Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.

Authors:  Michele Iacono; Laura Villa; Daniela Fortini; Roberta Bordoni; Francesco Imperi; Raoul J P Bonnal; Thomas Sicheritz-Ponten; Gianluca De Bellis; Paolo Visca; Antonio Cassone; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

7.  Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy).

Authors:  S D'Arezzo; A Capone; N Petrosillo; P Visca; M Ballardini; S Bartolini; E Bordi; A Di Stefano; M Galiè; R Minniti; M Meledandri; L Pacciani; G Parisi; G Prignano; C Santini; M Valmarin; M Venditti; S Ziantoni
Journal:  Clin Microbiol Infect       Date:  2009-04       Impact factor: 8.067

8.  Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy.

Authors:  R E Mendes; T Spanu; L Deshpande; M Castanheira; R N Jones; G Fadda
Journal:  Clin Microbiol Infect       Date:  2009-04-27       Impact factor: 8.067

9.  Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii.

Authors:  J F Turton; J Matos; M E Kaufmann; T L Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-20       Impact factor: 3.267

10.  Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii.

Authors:  Pauline D Mugnier; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more
  17 in total

1.  Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern France.

Authors:  A Pantel; H Marchandin; M-F Prère; A Boutet-Dubois; N Brieu-Roche; A Gaschet; A Davin-Regli; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-23       Impact factor: 3.267

2.  Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients.

Authors:  J Kristie Johnson; Gwen L Robinson; LiCheng Zhao; Anthony D Harris; O Colin Stine; Kerri A Thom
Journal:  Diagn Microbiol Infect Dis       Date:  2016-08-27       Impact factor: 2.803

3.  Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents.

Authors:  Tingting Zhang; Min Wang; Yixin Xie; Xianping Li; Zhihui Dong; Yanhua Liu; Ling Wang; Min Yang; Huan Song; Hong Cao; Wei Cao
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

4.  First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.

Authors:  P Espinal; M D Macià; I Roca; E Gato; E Ruíz; F Fernández-Cuenca; A Oliver; J Rodríguez-Baño; G Bou; M Tomás; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

5.  French regional surveillance program of carbapenemase-producing Gram-negative bacilli: results from a 2-year period.

Authors:  A Pantel; A Boutet-Dubois; H Jean-Pierre; H Marchandin; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-19       Impact factor: 3.267

6.  Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain.

Authors:  Noraida Mosqueda; Paula Espinal; Clara Cosgaya; Sergio Viota; Virginia Plasensia; Francisco Alvarez-Lerma; Milagro Montero; Julià Gómez; Juan Pablo Horcajada; Jordi Vila; Ignasi Roca
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

7.  Longitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methods.

Authors:  Brooke K Decker; Federico Perez; Andrea M Hujer; Kristine M Hujer; Geraldine S Hall; Michael R Jacobs; Wondwossen A Gebreyes; Scott T Zoll; Christian Massire; Mark W Eshoo; David J Ecker; Philip N Rather; Robert A Bonomo
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

8.  The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.

Authors:  Giancarlo Ceccarelli; Alessandra Oliva; Gabriella d'Ettorre; Alessandra D'Abramo; Elena Caresta; Caterina Silvia Barbara; Maria Teresa Mascellino; Paola Papoff; Corrado Moretti; Vincenzo Vullo; Paolo Visca; Mario Venditti
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

9.  Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis.

Authors:  Yolande Hauck; Charles Soler; Patrick Jault; Audrey Mérens; Patrick Gérome; Christine Mac Nab; François Trueba; Laurent Bargues; Hoang Vu Thien; Gilles Vergnaud; Christine Pourcel
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.

Authors:  Weiyuan Wu; Yi He; Jian Lu; Yuemei Lu; Jinsong Wu; Yingxia Liu
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.